Artigo Produção Nacional Revisado por pares

Plasma Brain-Derived Neurotrophic Factor in Women With Pelvic Pain: A Potential Biomarker for Endometriosis?

2017; Future Medicine; Volume: 11; Issue: 4 Linguagem: Inglês

10.2217/bmm-2016-0327

ISSN

1752-0371

Autores

Ana Luiza Lunardi Rocha, Érica Leandro Marciano Vieira, Márcia Cristina França Ferreira, Laura M. Maia, Antônio Lúcio Teixeira, Fernando M. Reis,

Tópico(s)

Cardiovascular, Neuropeptides, and Oxidative Stress Research

Resumo

Aim: To test whether plasma BDNF levels are useful to predict the presence of endometriosis in women with pelvic pain. Patients & methods: Prospective cross-sectional study including 67 consecutive women aged 24–49 years, scheduled for laparoscopy due to chronic pelvic pain. Preoperative plasma samples were assayed for BDNF using a commercial enzyme immunoassay. Results: Women with ovarian endometrioma had higher preoperative plasma BDNF (1063 ± 157 pg/ml) compared with women with other benign ovarian tumors (537 ± 131 pg/ml, F = 2.53; p = 0.02). However, plasma BDNF levels were not helpful to indicate the presence of peritoneal or deep infiltrating endometriosis. Plasma BDNF levels were positively correlated with the severity of pelvic pain (r = 0.489; p < 0.0001). Conclusion: Plasma BDNF might be a biomarker of ovarian endometrioma but not a useful diagnostic marker to detect other forms of endometriosis in women with painful symptoms.

Referência(s)
Altmetric
PlumX